Detail of the clinical trial

Title of the trial A randomised, phase 2 trial with infliximab (Remicade) in patients with myelodysplastic syndrome and a relatively low risk of developing acute leukemia
EudraCT number 2005-000679-16
Protocol number EORTC06023
Sponsor European Organisation for Research and Treatment of Cancer, Brussels, Belgium
Indications Hemato-oncology
Diagnosis acute leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2005
Date of approval by Institute (SÚKL) 17.05.2005
Date of approval by EC 19.04.2005
Date of initiation CT in ČR
Date of ending CT in ČR 30.09.2011
Notice
Sites Hematologické oddělení, Ústav hematologie a krevní transfuze, U Nemocnice 1, 128 20 PRAHA 2
Hematologická klinika, Fakultní nemocnice Olomouc, I. P. Pavlova 6, 775 20 OLOMOUC
Hematologické oddělení, Všeobecná fakultní nemocnice v Praze, U Nemocnice 2, 128 08 PRAHA 2

‹‹ Back to list